The aging population in Japan is not only driving the medical care and pharmaceutical industry but also the medical devi...
Singapore: Eribulin, an anticancer drug marketed by Japan-based Eisai under the trade name Halaven, has received reimbur...
Singapore: Eisai has decided to launch its AMPA receptor antagonist Fycompa (perampanel), a first-in-class anti-epilepti...
The pioneering research of Nobel Laureates Sir John Gurdon and Dr Shinya Yamanaka on reprogramming adult stem cells has ...
Singapore: Takeda Global Research and Development, a wholly owned subsidiary of Takeda Pharmaceutical, has filed seven n...
Singapore: Takeda Pharmaceutical and its wholly-owned subsidiary, Takeda Pharmaceuticals USA, have announced that the US...
New Delhi: Aiming at becoming one of the global manufacturing hubs, besides being a large healthcare market, India has i...
Singapore: Japan's top pharma companies, including Astellas, Eisai, Daiichi Sankyo, Shionogi, and Takeda, have come toge...
Singapore: The WHO has prequalified Eisai's drug NTD002, a 100 mg tablet of diethylcarbamazine (DEC) for treatment of el...
The fifth edition of the annual BioSpectrum Asia Pacific clinical research organization (CRO) Survey, which is conduct...
Singapore: The wholly-owned US subsidiary of Sysmex, Sysmex America, has won the seventh annual Pinnacle Award presented...
Singapore: Mr Yoshihiro Arai, currently general manager and head of development of Solasia Pharma, has been promoted to...
Singapore: Medical Device and Diagnostic Industry (MD+DI) recently published an original infographic and supporting arti...
Singapore: The intellectual property and science business of Thomson Reuters has collaborated with Japan's Tohoku Univer...
Singapore: Proteus Digital Health and Otsuka Pharmaceutical, a subsidiary of Japan-headquartered Otsuka Group, have ente...
Singapore: Swiss chemicals and drug company Lonza and USA-based BioWa, a wholly-owned subsidiary of Japan's Kyowa Hakko ...
Singapore: A joint panel of members from the Gastrointestinal Drugs and Drug Safety and Risk Management Advisory Committ...
